MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 159 filers reported holding MERSANA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $736,332 | -84.9% | 579,789 | -60.8% | 0.00% | – |
| Q2 2023 | $4,867,545 | +378.3% | 1,479,497 | +497.5% | 0.00% | – |
| Q1 2023 | $1,017,760 | +40.8% | 247,630 | +100.7% | 0.00% | – |
| Q4 2022 | $722,990 | -50.4% | 123,377 | -42.8% | 0.00% | – |
| Q3 2022 | $1,458,000 | +155.8% | 215,721 | +74.8% | 0.00% | – |
| Q2 2022 | $570,000 | +12.9% | 123,379 | -2.6% | 0.00% | – |
| Q1 2022 | $505,000 | -33.3% | 126,703 | +4.1% | 0.00% | – |
| Q4 2021 | $757,000 | -66.3% | 121,687 | -48.9% | 0.00% | – |
| Q3 2021 | $2,245,000 | -56.5% | 238,034 | -37.4% | 0.00% | – |
| Q2 2021 | $5,161,000 | -56.2% | 380,029 | -47.9% | 0.00% | -100.0% |
| Q1 2021 | $11,794,000 | -55.0% | 728,929 | -26.0% | 0.00% | -50.0% |
| Q4 2020 | $26,218,000 | +60.3% | 985,255 | +12.2% | 0.00% | 0.0% |
| Q3 2020 | $16,355,000 | -34.4% | 878,329 | -17.5% | 0.00% | -33.3% |
| Q2 2020 | $24,916,000 | +3419.2% | 1,064,788 | +776.9% | 0.00% | – |
| Q1 2020 | $708,000 | -51.8% | 121,423 | -52.6% | 0.00% | – |
| Q4 2019 | $1,469,000 | +261.8% | 256,328 | -0.3% | 0.00% | – |
| Q3 2019 | $406,000 | -61.0% | 257,228 | +0.2% | 0.00% | – |
| Q2 2019 | $1,040,000 | -22.9% | 256,778 | +0.2% | 0.00% | – |
| Q1 2019 | $1,349,000 | +29.1% | 256,328 | 0.0% | 0.00% | – |
| Q4 2018 | $1,045,000 | -59.2% | 256,328 | 0.0% | 0.00% | – |
| Q3 2018 | $2,563,000 | -44.0% | 256,328 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $4,578,000 | +13.2% | 256,328 | -0.1% | 0.00% | – |
| Q1 2018 | $4,045,000 | -7.6% | 256,462 | -3.7% | 0.00% | -100.0% |
| Q4 2017 | $4,377,000 | -85.4% | 266,406 | -84.6% | 0.00% | -75.0% |
| Q3 2017 | $29,999,000 | +25.4% | 1,735,061 | 0.0% | 0.00% | +33.3% |
| Q2 2017 | $23,926,000 | – | 1,735,061 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 5,000,000 | $6,350,000 | 1.92% |
| VR Adviser, LLC | 11,328,000 | $14,386,560 | 1.51% |
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $11,002,865 | 1.23% |
| Affinity Asset Advisors, LLC | 2,850,000 | $3,619,500 | 1.02% |
| EcoR1 Capital, LLC | 19,364,688 | $24,593,154 | 0.83% |
| Altium Capital Management LP | 1,059,136 | $1,345,103 | 0.70% |
| 5AM Venture Management, LLC | 1,305,000 | $1,657,350 | 0.48% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $1,148,420 | 0.38% |
| COMMODORE CAPITAL LP | 2,244,378 | $2,850,360 | 0.33% |
| Philosophy Capital Management LLC | 2,342,634 | $2,975,145 | 0.32% |